Shares of The Joint Corp. (NASDAQ:JYNT) hit a new 52-week high during trading on Tuesday . The stock traded as high as $4.86 and last traded at $4.98, with a volume of 42,252 shares changing hands. The stock had previously closed at $4.43.

JYNT has been the topic of several analyst reports. Craig Hallum initiated coverage on The Joint Corp. in a report on Wednesday, June 14th. They issued a “buy” rating and a $5.75 target price on the stock. Zacks Investment Research upgraded The Joint Corp. from a “sell” rating to a “hold” rating in a report on Wednesday, May 10th. ValuEngine upgraded The Joint Corp. from a “sell” rating to a “hold” rating in a report on Tuesday, June 6th. Maxim Group reiterated a “buy” rating and issued a $7.00 target price on shares of The Joint Corp. in a report on Friday, August 11th. Finally, Roth Capital initiated coverage on The Joint Corp. in a report on Thursday, July 27th. They issued a “buy” rating and a $5.70 target price on the stock. One research analyst has rated the stock with a sell rating, one has assigned a hold rating and four have assigned a buy rating to the stock. The stock currently has an average rating of “Buy” and a consensus target price of $5.61.

The company’s 50 day moving average is $3.93 and its 200 day moving average is $3.88. The company’s market cap is $63.12 million.

The Joint Corp. (NASDAQ:JYNT) last posted its earnings results on Thursday, August 10th. The company reported ($0.08) earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.09) by $0.01. The Joint Corp. had a negative return on equity of 103.25% and a negative net margin of 48.08%. The firm had revenue of $6.02 million for the quarter, compared to analysts’ expectations of $5.76 million. On average, equities analysts predict that The Joint Corp. will post ($0.33) EPS for the current fiscal year.

In other The Joint Corp. news, CFO John P. Meloun bought 6,850 shares of The Joint Corp. stock in a transaction dated Tuesday, June 27th. The shares were purchased at an average cost of $3.69 per share, with a total value of $25,276.50. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director James H. Amos, Jr. bought 10,000 shares of The Joint Corp. stock in a transaction dated Friday, June 30th. The shares were acquired at an average cost of $3.85 per share, for a total transaction of $38,500.00. Following the completion of the purchase, the director now directly owns 57,295 shares of the company’s stock, valued at approximately $220,585.75. The disclosure for this purchase can be found here. Insiders have bought 20,670 shares of company stock worth $78,140 over the last three months. Insiders own 6.10% of the company’s stock.

Institutional investors and hedge funds have recently bought and sold shares of the company. White Pine Capital LLC increased its stake in shares of The Joint Corp. by 44.2% during the second quarter. White Pine Capital LLC now owns 55,500 shares of the company’s stock valued at $211,000 after buying an additional 17,000 shares during the period. Russell Investments Group Ltd. increased its stake in shares of The Joint Corp. by 3.8% during the first quarter. Russell Investments Group Ltd. now owns 70,400 shares of the company’s stock valued at $296,000 after buying an additional 2,600 shares during the period. Boston Partners increased its stake in shares of The Joint Corp. by 13.1% during the second quarter. Boston Partners now owns 150,900 shares of the company’s stock valued at $573,000 after buying an additional 17,500 shares during the period. Captrust Financial Advisors purchased a new position in shares of The Joint Corp. during the second quarter valued at approximately $791,000. Finally, Sanders Morris Harris LLC increased its stake in shares of The Joint Corp. by 0.5% during the second quarter. Sanders Morris Harris LLC now owns 2,619,807 shares of the company’s stock valued at $9,955,000 after buying an additional 12,000 shares during the period. 47.03% of the stock is currently owned by hedge funds and other institutional investors.

COPYRIGHT VIOLATION NOTICE: “The Joint Corp. (JYNT) Hits New 1-Year High at $4.86” was originally reported by Daily Political and is the property of of Daily Political. If you are viewing this article on another publication, it was copied illegally and republished in violation of U.S. and international copyright and trademark legislation. The legal version of this article can be viewed at https://www.dailypolitical.com/2017/09/07/the-joint-corp-jynt-hits-new-1-year-high-at-4-86.html.

The Joint Corp. Company Profile

The Joint Corp. develops, owns, operates, supports and manages chiropractic clinics through direct ownership, management arrangements, franchising and the sale of regional developer rights throughout the United States. The Company is franchisor and operator of chiropractic clinics. The Company offers its patients the opportunity to visit its clinics without an appointment and receive prompt attention.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.